Karl-Erik Andersson to Signal Transduction
This is a "connection" page, showing publications Karl-Erik Andersson has written about Signal Transduction.
Connection Strength
0.860
-
Birder L, Andersson KE. Urothelial signaling. Physiol Rev. 2013 Apr; 93(2):653-80.
Score: 0.296
-
Drumm BT, Koh SD, Andersson KE, Ward SM. Calcium signalling in Cajal-like interstitial cells of the lower urinary tract. Nat Rev Urol. 2014 Oct; 11(10):555-64.
Score: 0.082
-
Andersson KE, McCloskey KD. Lamina propria: the functional center of the bladder? Neurourol Urodyn. 2014 Jan; 33(1):9-16.
Score: 0.075
-
Andersson KE, de Groat WC, McVary KT, Lue TF, Maggi M, Roehrborn CG, Wyndaele JJ, Melby T, Viktrup L. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn. 2011 Mar; 30(3):292-301.
Score: 0.064
-
Björkelund H, Gedda L, Andersson K. Comparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular context. PLoS One. 2011 Jan 31; 6(1):e16536.
Score: 0.064
-
Ekman M, Andersson KE, Arner A. Signal transduction pathways of muscarinic receptor mediated activation in the newborn and adult mouse urinary bladder. BJU Int. 2009 Jan; 103(1):90-7.
Score: 0.054
-
Andersson KE, Christ GJ. Regenerative pharmacology: the future is now. Mol Interv. 2007 Apr; 7(2):79-86.
Score: 0.049
-
Uckert S, Hedlund P, Waldkirch E, Sohn M, Jonas U, Andersson KE, Stief CG. Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone. World J Urol. 2004 Oct; 22(4):261-6.
Score: 0.040
-
Hillerdal V, Boura VF, Björkelund H, Andersson K, Essand M. Avidity characterization of genetically engineered T-cells with novel and established approaches. BMC Immunol. 2016 07 13; 17(1):23.
Score: 0.023
-
Birder LA, Andersson KE, Kanai AJ, Hanna-Mitchell AT, Fry CH. Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013. Neurourol Urodyn. 2014 Jun; 33(5):597-601.
Score: 0.020
-
Hennenberg M, Miljak M, Herrmann D, Strittmatter F, Walther S, Rutz B, Hocaoglu Y, Kunit T, Schreiber A, Andersson KE, Stief CG, Gratzke C. The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle. Am J Physiol Renal Physiol. 2013 Nov 15; 305(10):F1383-90.
Score: 0.019
-
Soler R, Andersson KE, Chancellor MB, Chapple CR, de Groat WC, Drake MJ, Gratzke C, Lee R, Cruz F. Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms. Eur Urol. 2013 Oct; 64(4):610-21.
Score: 0.019
-
Li K, Yao J, Sawada N, Kitamura M, Andersson KE, Takeda M. ß-Catenin signaling contributes to platelet derived growth factor elicited bladder smooth muscle cell contraction through up-regulation of Cx43 expression. J Urol. 2012 Jul; 188(1):307-15.
Score: 0.017
-
Weinhold P, Gratzke C, Streng T, Stief C, Andersson KE, Hedlund P. TRPA1 receptor induced relaxation of the human urethra involves TRPV1 and cannabinoid receptor mediated signals, and cyclooxygenase activation. J Urol. 2010 May; 183(5):2070-6.
Score: 0.015
-
Ekman M, Andersson KE, Arner A. Receptor-induced phasic activity of newborn mouse bladders is inhibited by protein kinase C and involves T-type Ca2+ channels. BJU Int. 2009 Sep; 104(5):690-7.
Score: 0.014
-
Oelke M, Hedlund P, Albrecht K, Ellinghaus P, Stief CG, Jonas U, Andersson KE, Uckert S. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study. Urology. 2006 May; 67(5):1111-6.
Score: 0.011